Novo Nordisk and AWS Expand Agentic AI in Drug Discovery
The pharmaceutical industry is rapidly embracing artificial intelligence, and Novo Nordisk is taking another major step toward integrating AI into drug discovery and research. The Danish healthcare company is expanding its use of Amazon Web Services (AWS) artificial intelligence technologies to support scientific research, target identification, therapy design, biological analysis, and other research workflows. Under … Read more